258 related articles for article (PubMed ID: 20176643)
1. Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease.
Dongiovanni P; Valenti L; Rametta R; Daly AK; Nobili V; Mozzi E; Leathart JB; Pietrobattista A; Burt AD; Maggioni M; Fracanzani AL; Lattuada E; Zappa MA; Roviaro G; Marchesini G; Day CP; Fargion S
Gut; 2010 Feb; 59(2):267-73. PubMed ID: 20176643
[TBL] [Abstract][Full Text] [Related]
2. Polycystic ovary syndrome is associated with genetic polymorphism in the insulin signaling gene IRS-1 but not ENPP1 in a Japanese population.
Baba T; Endo T; Sata F; Honnma H; Kitajima Y; Hayashi T; Manase K; Kanaya M; Yamada H; Minakami H; Kishi R; Saito T
Life Sci; 2007 Aug; 81(10):850-4. PubMed ID: 17719609
[TBL] [Abstract][Full Text] [Related]
3. Association of ENPP1 (PC-1) K121Q polymorphism with obesity-related parameters in subjects with metabolic syndrome.
González-Sánchez JL; Zabena C; Martínez-Larrad MT; Martínez-Calatrava MJ; Pérez-Barba M; Serrano-Ríos M
Clin Endocrinol (Oxf); 2008 May; 68(5):724-9. PubMed ID: 17986276
[TBL] [Abstract][Full Text] [Related]
4. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver.
Xing LJ; Zhang L; Liu T; Hua YQ; Zheng PY; Ji G
Eur J Pharmacol; 2011 Oct; 668(3):467-71. PubMed ID: 21839075
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in non-alcoholic fatty liver disease: interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis.
Carulli L; Canedi I; Rondinella S; Lombardini S; Ganazzi D; Fargion S; De Palma M; Lonardo A; Ricchi M; Bertolotti M; Carulli N; Loria P
Dig Liver Dis; 2009 Nov; 41(11):823-8. PubMed ID: 19403348
[TBL] [Abstract][Full Text] [Related]
6. ENPP1 gene, insulin resistance and related clinical outcomes.
Bacci S; De Cosmo S; Prudente S; Trischitta V
Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):403-9. PubMed ID: 17563456
[TBL] [Abstract][Full Text] [Related]
7. Obesity risk associated with the K121Q polymorphism of the glycoprotein PC-1 gene.
Wan C; Zhang T; Wang B; Han Y; Zhang C; Zhang Y; Gong H; Jin F; Wang L
Diabetes Obes Metab; 2006 Nov; 8(6):703-8. PubMed ID: 17026496
[TBL] [Abstract][Full Text] [Related]
8. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
Stefanović V; Antić S
Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
[TBL] [Abstract][Full Text] [Related]
9. Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity.
Chin CN; Dallas-Yang Q; Liu F; Ho T; Ellsworth K; Fischer P; Natasha T; Ireland C; Lu P; Li C; Wang IM; Strohl W; Berger JP; An Z; Zhang BB; Jiang G
Eur J Pharmacol; 2009 Mar; 606(1-3):17-24. PubMed ID: 19374858
[TBL] [Abstract][Full Text] [Related]
10. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Enjoji M; Takayanagi R; Nakamuta M
Int J Mol Med; 2008 Apr; 21(4):507-11. PubMed ID: 18360697
[TBL] [Abstract][Full Text] [Related]
11. New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals.
Bochenski J; Placha G; Wanic K; Malecki M; Sieradzki J; Warram JH; Krolewski AS
Diabetes; 2006 Sep; 55(9):2626-30. PubMed ID: 16936213
[TBL] [Abstract][Full Text] [Related]
12. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease.
Aller R; De Luis DA; Fernandez L; Calle F; Velayos B; Izaola O; Gonzalez Sagrado M; Conde R; Gonzalez JM
Eur Rev Med Pharmacol Sci; 2009; 13(5):357-64. PubMed ID: 19961041
[TBL] [Abstract][Full Text] [Related]
13. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors.
Loria P; Lonardo A; Lombardini S; Carulli L; Verrone A; Ganazzi D; Rudilosso A; D'Amico R; Bertolotti M; Carulli N
J Gastroenterol Hepatol; 2005 Aug; 20(8):1176-84. PubMed ID: 16048564
[TBL] [Abstract][Full Text] [Related]
14. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease.
Targher G; Bertolini L; Scala L; Cigolini M; Zenari L; Falezza G; Arcaro G
Nutr Metab Cardiovasc Dis; 2007 Sep; 17(7):517-24. PubMed ID: 16928437
[TBL] [Abstract][Full Text] [Related]
15. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
Savvidou S; Hytiroglou P; Orfanou-Koumerkeridou H; Panderis A; Frantzoulis P; Goulis J
J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
[TBL] [Abstract][Full Text] [Related]
16. TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis.
Valenti L; Pulixi E; Fracanzani AL; Dongiovanni P; Maggioni M; Orsatti A; Gianni C; Fargion S
J Hepatol; 2005 Dec; 43(6):944-50. PubMed ID: 16143422
[TBL] [Abstract][Full Text] [Related]
17. The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease.
Nakamuta M; Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Yada M; Yada R; Takemoto R; Fukuizumi K; Harada N; Taketomi A; Maehara Y; Nakashima M; Enjoji M
Int J Mol Med; 2008 Nov; 22(5):663-7. PubMed ID: 18949388
[TBL] [Abstract][Full Text] [Related]
18. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
[TBL] [Abstract][Full Text] [Related]
19. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Rodella S; Zoppini G; Zenari L; Falezza G
Clin Endocrinol (Oxf); 2006 Mar; 64(3):337-41. PubMed ID: 16487446
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease in severely obese subjects.
Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
